Invus Public Equities Advisors, LLC

CIK 00013400969 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001340096

Recent Transactions

50 trades

Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2024-12-10$41.65/sh−1,600,000→ 9,250,005 total
Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2024-11-25$38.43/sh−43,887→ 11,007,279 total
Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2024-11-25$39.51/sh−126,442→ 10,880,837 total
Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2024-11-25$40.98/sh−149→ 10,850,005 total
Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2024-11-25$37.63/sh−208,272→ 11,051,166 total
Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2024-11-25$40.14/sh−30,683→ 10,850,154 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2024-08-08$0.19/sh−260,873→ 6,317,565 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2024-08-07$0.18/sh−61,488→ 6,578,438 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2024-08-06$0.18/sh−55,732→ 6,639,926 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2024-08-05$0.19/sh−164,523→ 6,695,658 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2024-08-02$0.20/sh−286,200→ 6,860,181 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2024-08-01$0.22/sh−63,564→ 7,146,381 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2024-07-30$0.22/sh−756,835→ 7,209,945 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2024-07-29$0.24/sh−363,949→ 7,966,780 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2024-07-26$0.24/sh−258,335→ 8,330,729 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922→ 1,150,922 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-05-10+57,546,100→ 136,180,481 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Series A Convertible Preferred Stock
2024-03-13$108.50/sh+1,150,922→ 1,150,922 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$6.85/sh+2,189,781→ 11,249,288 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$8.55/sh+10,150→ 11,259,438 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-04-28$6.43/sh+31,557→ 9,059,507 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-24$1.70/sh+100,000→ 8,589,064 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-23$1.75/sh+200,000→ 8,489,064 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-22$1.79/sh+150,000→ 8,289,064 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-21$1.85/sh+50,000→ 8,139,064 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-17$1.71/sh+200,000→ 8,089,064 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-16$1.68/sh+315,266→ 7,889,064 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-15$2.16/sh+1,000,000→ 7,573,798 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-09$3.24/sh+11,451→ 6,573,798 total
Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2023-01-09$9.48/sh−1,094→ 9,027,950 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-01-05$9.33/sh+48,774→ 9,029,044 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2022-10-25$8.04/sh+130,265→ 8,980,270 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2022-10-04$7.89/sh+66,000→ 8,850,005 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2022-10-03$7.03/sh+33,971→ 8,784,005 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-08-05$2.50/sh+2,426,070→ 50,859,331 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-08-01$2.50/sh+16,173,800→ 48,433,261 total
Conversion
Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
2021-08-03−5,000,000→ 0 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2021-08-03$17.00/sh+875,000→ 2,273,530 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+1,323,530→ 1,398,530 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2021-07-30$16.14/sh+75,000→ 75,000 total
Sale
Seer, Inc.$SEER
Class A Common Stock
2021-02-01$64.15/sh−252,545→ 5,588,366 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-12-16$3.20/sh+10,937,500→ 32,259,461 total
Conversion
Seer, Inc.$SEER
Class A Common Stock
2020-12-08+5,050,911→ 5,050,911 total
Purchase
Seer, Inc.$SEER
Class A Common Stock
2020-12-08$19.00/sh+790,000→ 5,840,911 total
Conversion
Seer, Inc.$SEER
Series D Convertible Preferred Stock
2020-12-08−474,478→ 0 total
Conversion
Seer, Inc.$SEER
Series C Convertible Preferred Stock
2020-12-08−373,831→ 0 total
Conversion
Seer, Inc.$SEER
Series D-1 Convertible Preferred Stock
2020-12-08−249,221→ 0 total
Conversion
Seer, Inc.$SEER
Series B Convertible Preferred Stock
2020-12-08−3,953,381→ 0 total

Companies

Recent Filings

Address

750 LEXINGTON AVENUE 30TH FLOOR

NEW YORK, NY, 10022

View on SEC.gov